Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02448810
Title Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baxalta US Inc.
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin

Imalumab

Panitumumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.